Concepedia

Guido Giordano

GG

Statistics

Publications

28

Citations

778

H-Index

15

Active since

1985

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Casa Sollievo della Sofferenza

University of Campania "Luigi Vanvitelli"

University of Foggia

University of Verona

Guido Giordano is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, cancer research, and pathology.

ORCID

Top concepts

Publications per year

1985–2024

28

Publications

28

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data

Margherita Rimini, Lorenzo Fornaro, Sara Lonardi et al. · Liver International · 2023 · 110 citations · Full text

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

Fortunato Ciardiello, Nicola Normanno, Erika Martinelli et al. · Annals of Oncology · 2016 · 97 citations

, , +8

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer

Guido Giordano, Antonio Febbraro, Eugenio Tomaselli et al. · Journal of Experimental & Clinical Cancer Research · 2015 · 84 citations · Full text

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice

Ferdinando De Vita, Jole Ventriglia, Antonio Febbraro et al. · BMC Cancer · 2016 · 57 citations · Full text

JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer

Guido Giordano, Pietro Parcesepe, Mario D’Andrea et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 42 citations · Full text

1–5 of 28